Events

SAMHD1 expression in residual disease is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Ester Ballana & Mireia Margelí

IrsiCaixa / HUGTiP&ICO

Host: CARE Program

Date and time: | 16.00

Venue: Sala Polivalent, IGTP Mar and online

Els Seminaris Translacionals en càncer de l'IGTP és una iniciativa que va nèixer amb els objectius de donar a conèixer la recerca translacional en càncer al nostre territori, així com impulsar nous projectes col·laboratius i generar un espai de debat científic enriquidor entre participants.

The Translational Cancer Seminars of the IGTP is an initiative that was born with the objectives of raising awareness of translational research in cancer in our territory, as well as promoting new collaborative projects and generating a space for boosting scientific debate among participants.

Speakers

Ester Ballana, principal investigator at IrsiCaixa, Virus-Host Interactions research group (ViHIT).

Mireia Margelí, oncologist at ICO Badalona – Germans Trias i Pujol Hospital (HUGTiP).

Join the talk on streaming here